{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:50:58Z","timestamp":1776693058877,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T00:00:00Z","timestamp":1636243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bbrc.2021.10.078","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T21:36:00Z","timestamp":1635888960000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Therapeutic effects of CXCL9-overexpressing human umbilical cord mesenchymal stem cells on liver fibrosis in rats"],"prefix":"10.1016","volume":"584","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiantao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9751-6577","authenticated-orcid":false,"given":"Ye","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueshuai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.bbrc.2021.10.078_bib1","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.3748\/wjg.v20.i23.7260","article-title":"Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: an update","volume":"20","author":"Elpek","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2021.10.078_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2021.10.078_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2015.03.002","article-title":"Engineering mesenchymal stem cells for regenerative medicine and drug delivery","volume":"84","author":"Park","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.bbrc.2021.10.078_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/jcmm.14788","article-title":"Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases","volume":"24","author":"Hu","year":"2020","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2021.10.078_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136777","article-title":"Liver disease: induction, progression, immunological mechanisms, and therapeutic interventions","volume":"22","author":"Neshat","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2021.10.078_bib6","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/MEG.0b013e32832a1f6c","article-title":"Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial","volume":"21","author":"Kharaziha","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2021.10.078_bib7","first-page":"831","article-title":"Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury","volume":"6","author":"Xagorari","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbrc.2021.10.078_bib8","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.20469","article-title":"In\u00a0vitro hepatic differentiation of human mesenchymal stem cells","volume":"40","author":"Lee","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2021.10.078_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.semcdb.2019.10.014","article-title":"Anti-fibrotic mechanisms of exogenously-expanded mesenchymal stromal cells for fibrotic diseases","volume":"101","author":"Rockel","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2021.10.078_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1535370219898141","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bbrc.2021.10.078_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2021.10.078_bib12","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hep.25545","article-title":"Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice","volume":"55","author":"Sahin","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2021.10.078_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41423-019-0279-0","article-title":"CCL5 deficiency promotes liver repair by improving inflammation resolution and liver regeneration through M2 macrophage polarization","volume":"17","author":"Li","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbrc.2021.10.078_bib14","doi-asserted-by":"crossref","first-page":"655268","DOI":"10.3389\/fmed.2021.655268","article-title":"The application of mesenchymal stem cells in the treatment of liver diseases: mechanism, efficacy, and safety issues","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrc.2021.10.078_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.gastro.2009.03.053","article-title":"Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans","volume":"137","author":"Wasmuth","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2021.10.078_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025663","article-title":"Mesenchymal stem cells exhibit firm adhesion, crawling, spreading and transmigration across aortic endothelial cells: effects of chemokines and shear","volume":"6","author":"Chamberlain","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2021.10.078_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: direct antifibrotic agents and targeted therapies","volume":"68\u201369","author":"Schuppan","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbrc.2021.10.078_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2021.10.078_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/17474124.2018.1555469","article-title":"An update on the pathogenesis and clinical management of cirrhosis with refractory ascites","volume":"13","author":"Neong","year":"2019","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2021.10.078_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11010-017-2940-1","article-title":"Anti-TGF\u03b2-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGF\u03b2-1\/Smad pathway","volume":"429","author":"Xuan","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2021.10.078_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s13287-020-01895-1","article-title":"Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury","volume":"11","author":"Hu","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2021.10.078_bib22","first-page":"6546780","article-title":"Applications of mesenchymal stem cells in liver fibrosis: novel strategies, mechanisms, and clinical practice","volume":"2021","author":"Zhu","year":"2021","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.bbrc.2021.10.078_bib23","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1053\/j.gastro.2016.12.003","article-title":"Milk fat globule-EGF factor 8, secreted by mesenchymal stem cells, protects against liver fibrosis in mice","volume":"152","author":"An","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2021.10.078_bib24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3748\/wjg.v21.i3.742","article-title":"Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects","volume":"21","author":"Berardis","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2021.10.078_bib25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13287-017-0590-6","article-title":"Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease","volume":"8","author":"de Witte","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2021.10.078_bib26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13287-017-0614-2","article-title":"Overexpression of c-Met in bone marrow mesenchymal stem cells improves their effectiveness in homing and repair of acute liver failure","volume":"8","author":"Wang","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2021.10.078_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13287-020-1555-8","article-title":"Different approaches for transformation of mesenchymal stem cells into hepatocyte-like cells","volume":"11","author":"Afshari","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2021.10.078_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13287-018-1032-9","article-title":"Interleukin-1\u03b2 induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration","volume":"9","author":"Guo","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2021.10.078_bib29","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1478-3231.2011.02504.x","article-title":"Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases","volume":"31","author":"Tacke","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.bbrc.2021.10.078_bib30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2005.08.009","article-title":"Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives","volume":"25","author":"Chuang","year":"2005","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.bbrc.2021.10.078_bib31","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1086\/646614","article-title":"Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection","volume":"200","author":"Zeremski","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.bbrc.2021.10.078_bib32","doi-asserted-by":"crossref","first-page":"112365","DOI":"10.1016\/j.yexcr.2020.112365","article-title":"Expression and role of MIG\/CXCR3 axis in mantle cell lymphoma","volume":"397","author":"Zhu","year":"2020","journal-title":"Exp. Cell Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21015023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21015023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:41:53Z","timestamp":1762094513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21015023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":32,"alternative-id":["S0006291X21015023"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.10.078","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-742448\/v1","asserted-by":"object"}]},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effects of CXCL9-overexpressing human umbilical cord mesenchymal stem cells on liver fibrosis in rats","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.10.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}